The verified answer
As of Aug 2026, DEPLOY verifies MicroPort MedBot: 2 models. 3 sources back the record.
MicroPort MedBot holds 1 NMPA registration and 1 FDA 510(k) clearance, per the DEPLOY registry.
See all 2 filingsCategorySurgical robots
Overview
Shanghai MicroPort MedBot (Group) Co., Ltd. (HKEX: 02252) is a surgical robotics company spun out of MicroPort Scientific in 2015. Its flagship Toumai laparoscopic surgical robot has received regulatory approval in over 60 countries and achieved 100+ commercial orders, making it the leading Chinese-developed surgical robot globally. The company covers five surgical robotics subsectors: endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
CEO
Parent
Financial stage
Toumai orders
Countries
Data & sources
Press releases
1
Web sources
2
3 sources backing this record.View all →
Models (2)
View all models →Current platform
Toumai
The Toumai Endoscopic Surgical Robot is MicroPort MedBot's flagship laparoscopic surgical robotics system, featuring remote telesurgery capabilities. It became the world's first surgical robot to receive regulatory approval for commercial remote surgery in April 2025, and has been deployed in nearly 40 countries across six continents. Toumai has achieved 100+ commercial orders and 80+ installations worldwide, with notable deployments including Cleveland Clinic Abu Dhabi, Gemelli Hospital Italy, and AZ Delta Belgium.
Current platform
Toumai
MicroPort MedBot developed the Toumai, a four-arm laparoscopic surgical robot that became the first Chinese-developed surgical robot to receive NMPA regulatory clearance, granted in January 2022. The system uses 3D HD vision and wristed surgical instruments for minimally invasive procedures across urology, gynecology, and general surgery. A single-port variant, the Toumai SP, received separate NMPA clearance in March 2025, and a tele-operative version received NMPA approval in May 2025 as the first tele-surgical robot authorized for commercial clinical use globally.
MicroPort MedBot on the deployment map
View the global mapMicroPort MedBot has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for MicroPort MedBot on the DEPLOY record yet. Track MicroPort MedBot to know the moment the first one is verified.
Current leadership (1)
- Dr. Chao He Founder & PresidentSEC-verified
Safety record
No incidents on record for MicroPort MedBot.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
MicroPort MedBot in third-party press
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- Neocis2 models
- Remebot2 models
Financial state
- Reporting basis
- private_reported
- Revenue disclosed
- $38000000 (private_reported)
- Lifecycle stage
- growth
- Counterparty risk class
- moderate
- SEC filing
- other
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Regulatory filings (2)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 27, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 14, 2025
Toumai at Luanda, Angola
- Deployment verifiedVerifiedMay 26, 2025
Toumai at Aalst, Belgium
- Deployment verifiedVerifiedJan 1, 2024
Toumai at Mumbai, India
- Deployment verifiedVerifiedJan 1, 2024
Toumai at Bangkok, Thailand
Sources (3)
- https://www.medbotsurgical.com/en/news/53.html
- Toumai Surgical Robot Achieves Global Commercialization Milestone with 100 Orders · https://microport.com/news/toumai-surgical-robot-achieves-global-commercialization-milestone-with-100-orders
- MicroPort - Wikipedia · https://en.wikipedia.org/wiki/MicroPort
Common questions
What is MicroPort MedBot?
What does MicroPort MedBot make?
Is MicroPort MedBot publicly traded?
Who competes with MicroPort MedBot?
Who is the CEO of MicroPort MedBot?
How can I invest in MicroPort MedBot?
Where is MicroPort MedBot headquartered?
Who owns MicroPort MedBot?
Where does MicroPort MedBot operate robots?
Is MicroPort MedBot a top robotics company?
When was MicroPort MedBot founded?
Is MicroPort MedBot safe?
Methodology: Verified · 3 sources (1 primary) · last reviewed 2026-08-05
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 1
- unclassified
- Unclassified source
- 1
- primary-company-ir
- Company IR disclosure
- 1
- knowledge-base
- Knowledge base
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for MicroPort MedBot.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- Neocis2 models
- Remebot2 models
In the press
Recent coverage mentioning MicroPort MedBot from third-party publications. Automatically surfaced; not part of the verified registry record.
Toumai Surgical Robot Achieves Global Commercialization Milestone with 100 Orders
MicroPort MedBot announces 100 cumulative global commercial orders for Toumai, with 80+ installations across nearly 40 countries.
Toumai Completes World's First FDA-IDE Approved USA-Africa Robotic Telesurgery
World's first FDA-IDE approved robotic telesurgery performed across 17,000 km from Orlando to Luanda, Angola.
Exclusive: Groundbreaking remote robotic surgery - patient in Africa, doctor in Florida
ABC News exclusive on the first FDA-IDE approved transcontinental telesurgery from Orlando to Angola using Toumai.
Toumai Robot Enables First-Ever Intra-EU Telesurgery Cases
First intra-European telesurgeries completed using CE-certified Toumai between Orsi Academy and AZORG Hospital in Belgium with 20ms latency.
MicroPort - Wikipedia
Wikipedia article on MicroPort Scientific, parent of MicroPort MedBot, covering its history and surgical robotics subsidiary.
Machine-readable surfaces
- Markdown mirror: /companies/microport-medbot.md
- RSS feed: /companies/microport-medbot/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/ebba8794-a39c-4a89-81f3-e05ff9b81428
- Revision history: /companies/microport-medbot/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- Neocis2 models
- Remebot2 models
Video
The Medbot Toumai® Surgical Robot demonstrates exceptional control by suturing the delicate eggshell membrane between the eggshell and the egg white — a task th
Reality vs attention
MicroPort MedBot draws attention at the 1st percentile but verifies reality at the 93rd percentile among surgical robots. Hype Gap -92.2, 37th widest among surgical robots.
6-month trend
Analysis
Clean safety record across 8 verified deployments. Strong deployment footprint with 8 operational sites across 8 countries. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 17, 2026